Authors:
FORMENTI SC
SHRIVASTAVA PN
SAPOZINK M
JOZSEF G
CHAN KK
JEFFERS S
MORROW PC
MUGGIA FM
Citation: Sc. Formenti et al., ABDOMINOPELVIC HYPERTHERMIA AND INTRAPERITONEAL CARBOPLATIN IN EPITHELIAL OVARIAN-CANCER - FEASIBILITY, TOLERANCE AND PHARMACOLOGY, International journal of radiation oncology, biology, physics, 35(5), 1996, pp. 993-1001
Authors:
MUGGIA FM
LIU PY
ALBERTS DS
WALLACE DL
OTOOLE RV
TERADA KY
FRANKLIN EW
HERRER GW
GOLDBERG DA
HANNIGAN EV
Citation: Fm. Muggia et al., INTRAPERITONEAL MITOXANTRONE OR FLOXURIDINE - EFFECTS ON TIME-TO-FAILURE AND SURVIVAL IN PATIENTS WITH MINIMAL RESIDUAL OVARIAN-CANCER AFTER 2ND-LOOK LAPAROTOMY - A RANDOMIZED PHASE-II STUDY BY THE SOUTHWEST-ONCOLOGY-GROUP, Gynecologic oncology, 61(3), 1996, pp. 395-402
Authors:
TURRILL M
SPICER DV
KELLEY AS
HERMAN RL
RUSSELL CA
MUGGIA FM
Citation: M. Turrill et al., PHASE-II CLINICAL-TRIAL OF CARBOPLATIN, IFOSFAMIDE, WITH ORAL MESNA FOR METASTATIC BREAST-CARCINOMA, Cancer investigation, 13(2), 1995, pp. 160-164
Authors:
UZIELY B
JEFFERS S
ISACSON R
KUTSCH K
WEITSAO D
YEHOSHUA Z
LIBSON E
MUGGIA FM
GABIZON A
Citation: B. Uziely et al., LIPOSOMAL DOXORUBICIN - ANTITUMOR-ACTIVITY AND UNIQUE TOXICITIES DURING 2 COMPLEMENTARY PHASE-I STUDIES, Journal of clinical oncology, 13(7), 1995, pp. 1777-1785
Authors:
LEICHMAN CG
FLEMING TR
MUGGIA FM
TANGEN CM
ARDALAN B
DOROSHOW JH
MEYERS FJ
HOLCOMBE RF
WEISS GR
MANGALIK A
MACDONALD JS
Citation: Cg. Leichman et al., PHASE-II STUDY OF FLUOROURACIL AND ITS MODULATION IN ADVANCED COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(6), 1995, pp. 1303-1311
Authors:
ISRAEL VK
JIANG C
MUGGIA FM
TULPULE A
JEFFERS S
LEICHMAN L
MORROW CP
ROMAN L
LEICHMAN CG
CHAN KK
Citation: Vk. Israel et al., INTRAPERITONEAL 5-FLUORO-2'-DEOXYURIDINE (FUDR) AND (S)-LEUCOVORIN FOR DISEASE PREDOMINANTLY CONFINED TO THE PERITONEAL-CAVITY - A PHARMACOKINETIC AND TOXICITY STUDY, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 32-38
Citation: L. Muderspach et al., 2ND-LOOK LAPAROTOMY FOR STAGE-III EPITHELIAL OVARIAN-CANCER - RATIONALE AND CURRENT ISSUES, Cancer treatment reviews, 21(6), 1995, pp. 499-511
Authors:
MUGGIA FM
VAFAI D
NATALE R
ISRAEL V
ZARETSKY S
MCRAE A
ROGERS M
JEFFERS S
Citation: Fm. Muggia et al., PACLITAXEL 3-HOUR INFUSION GIVEN ALONE AND COMBINED WITH CARBOPLATIN - PRELIMINARY-RESULTS OF DOSE-ESCALATION TRIALS, Seminars in oncology, 22(4), 1995, pp. 63-66
Authors:
BUNN PA
ROWINSKY EK",KEARNS,RAGHAVAN,"MUGGIA FM",CALVERT,"CARNEY DN
BELANI CP
LANGER CJ
OZOLS RF
JOHNSON D
GIACCONE G",SHEA,"GRECO FA",GELMON,"HOFFMAN PC
CHOY H
AISNER J
Citation: Pa. Bunn et al., UNTITLED - DISCUSSION, Seminars in oncology, 22(4), 1995, pp. 83-85
Authors:
SALTZ LB
LEICHMAN CG
YOUNG CW
MUGGIA FM
CONTI JA
SPIESS T
JEFFERS S
LEICHMAN LP
Citation: Lb. Saltz et al., A FIXED-RATIO COMBINATION OF URACIL AND FTORAFUR (UFT) WITH LOW-DOSE LEUCOVORIN - AN ACTIVE ORAL REGIMEN FOR ADVANCED COLORECTAL-CANCER, Cancer, 75(3), 1995, pp. 782-785
Citation: Fm. Muggia et Kk. Chan, A PHASE-I TRIAL OF IMMEDIATE POSTOPERATIVE INTRAPERITONEAL FLOXURIDINE AND LEUCOVORIN PLUS SYSTEMIC 5-FLUOROURACIL AND LEVAMISOLE AFTER RESECTION OF HIGH-RISK COLON-CANCER, Cancer, 75(11), 1995, pp. 2782-2782
Citation: G. Los et Fm. Muggia, PLATINUM RESISTANCE - EXPERIMENTAL AND CLINICAL STATUS, Hematology/oncology clinics of North America, 8(2), 1994, pp. 411-429
Citation: Fm. Muggia, TENIPOSIDE - OVERVIEW OF ITS THERAPEUTIC POTENTIAL IN ADULT CANCERS, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000127-190000133
Authors:
MUGGIA FM
TULPULE A
RETZIOS A
CHEN F
JEFFERS S
LEICHMAN CG
LEICHMAN L
SPEARS CP
CHAN KK
Citation: Fm. Muggia et al., INTRAPERITONEAL 5-FLUORO-2'-DEOXYURIDINE WITH ESCALATING DOSES OF LEUCOVORIN - PHARMACOLOGY AND CLINICAL TOLERANCE, Investigational new drugs, 12(3), 1994, pp. 197-206
Citation: Fm. Muggia et L. Munderspach, PLATINUM COMPOUNDS IN CERVICAL AND ENDOMETRIAL CANCERS - FOCUS ON CARBOPLATIN, Seminars in oncology, 21(2), 1994, pp. 35-41
Authors:
DELAFLORWEISS E
GILL I
KORTES G
MUGGIA FM
Citation: E. Delaflorweiss et al., PHASE-I STUDY OF CARBOPLATIN DAY 1 WITH CISPLATIN DAY-3 - DOSING PER M2 VERSUS DOSING USING CALVERT FORMULA, Clinical research, 42(1), 1994, pp. 10000104-10000104
Citation: Ky. Chiu et al., GIANT-CELL CANCER OF THE LUNG (GCCL) AND LEUKOCYTOSIS - CLINICAL-EVIDENCE FOR SECRETION OF HUMORAL-FACTORS, Clinical research, 42(1), 1994, pp. 10000104-10000104
Authors:
RAY MS
MUGGIA FM
LEICHMAN CG
GRUNBERG SM
NELSON RL
DYKE RW
MORAN RG
Citation: Ms. Ray et al., PHASE-I STUDY OF (6R)-5,10-DIDEAZATETRAHYDROFOLATE - A FOLATE ANTIMETABOLITE INHIBITORY TO DE-NOVO PURINE SYNTHESIS, Journal of the National Cancer Institute, 85(14), 1993, pp. 1154-1159
Citation: E. Delaflorweiss et al., PROTRACTED DRUG INFUSIONS IN CANCER-TREATMENT - AN APPRAISAL OF 5-FLUOROURACIL, DOXORUBICIN, AND PLATINUMS, Annals of oncology, 4(9), 1993, pp. 723-733